[Skip to Content]
[Skip to Content Landing]
Other Articles
October 23, 1937

COMMUNITY PROVISION FOR THE SERUM TREATMENT OF PNEUMOCOCCIC PNEUMONIASREPORT OF THE COMMITTEE ON PUBLIC HEALTH RELATIONS OF THE NEW YORK ACADEMY OF MEDICINE BY A SPECIAL SUBCOMMITTEE:

JAMA. 1937;109(17):1323-1328. doi:10.1001/jama.1937.02780430001001
Abstract

I. THE PROBLEM OF THE PNEUMONIAS  It is well known that in our part of the world "pneumonia" is not only a very prevalent but a very deadly disease. The combined average lethal rate of the pneumonias is close to 25 per cent. As a cause of invalidism and death, the pneumonias outrank the communicable diseases of childhood. They occupy third place in the mortality bills of New York City, New York State and the United States death registration area and are preceded only by the diseases of the heart and by cancer. They take a very large toll among people of the most productive age groups. There are few prevalent acute conditions which have such a high mortality or are as expensive to treat.Within the last decade the curative value of concentrated specific immune horse serum has been established for the pneumococcic pneumonias of type I and type

First Page Preview View Large
First page PDF preview
First page PDF preview
×